Clegg J - Search Results

1

The cost-effectiveness of exenatide once weekly compared with exenatide twice daily and insulin glargine for the treatment of patients with type two diabetes and body mass index ≥30 kg/m(2) in Spain.

Fonseca T, Clegg J, Caputo G, Norrbacka K, Dilla T, Alvarez M. Fonseca T, et al. Among authors: clegg j. J Med Econ. 2013 Jul;16(7):926-38. doi: 10.3111/13696998.2013.803110. Epub 2013 May 31. J Med Econ. 2013. PMID: 23659201 Free article.

2

Review of utility values for economic modeling in type 2 diabetes.

Beaudet A, Clegg J, Thuresson PO, Lloyd A, McEwan P. Beaudet A, et al. Among authors: clegg j. Value Health. 2014 Jun;17(4):462-70. doi: 10.1016/j.jval.2014.03.003. Epub 2014 May 17. Value Health. 2014. PMID: 24969008 Free article. Review.

3

Cost-effectiveness of macrogol 4000 compared to lactulose in the treatment of chronic functional constipation in the UK.

Guest JF, Clegg JP, Helter MT. Guest JF, et al. Curr Med Res Opin. 2008 Jul;24(7):1841-52. doi: 10.1185/03007990802102349. Epub 2008 May 27. Curr Med Res Opin. 2008. PMID: 18558017

4

Modelling the cost-utility of bio-electric stimulation therapy compared to standard care in the treatment of elderly patients with chronic non-healing wounds in the UK.

Clegg JP, Guest JF. Clegg JP, et al. Curr Med Res Opin. 2007 Apr;23(4):871-83. doi: 10.1185/030079906x167705. Curr Med Res Opin. 2007. PMID: 17407644

5

Cost-utility of levonorgestrel intrauterine system compared with hysterectomy and second generation endometrial ablative techniques in managing patients with menorrhagia in the UK.

Clegg JP, Guest JF, Hurskainen R. Clegg JP, et al. Curr Med Res Opin. 2007 Jul;23(7):1637-48. doi: 10.1185/030079907x199709. Curr Med Res Opin. 2007. PMID: 17559758 Clinical Trial.

6

Cost effectiveness of cilostazol compared with naftidrofuryl and pentoxifylline in the treatment of intermittent claudication in the UK.

Guest JF, Davie AM, Clegg JP. Guest JF, et al. Curr Med Res Opin. 2005 Jun;21(6):817-26. doi: 10.1185/030079905X41471. Curr Med Res Opin. 2005. PMID: 15969881

7

The annual cost of dry eye syndrome in France, Germany, Italy, Spain, Sweden and the United Kingdom among patients managed by ophthalmologists.

Clegg JP, Guest JF, Lehman A, Smith AF. Clegg JP, et al. Ophthalmic Epidemiol. 2006 Aug;13(4):263-74. doi: 10.1080/09286580600801044. Ophthalmic Epidemiol. 2006. PMID: 16877285

8

Costs and consequences of using pamidronate compared with zoledronic acid in the management of breast cancer patients in the UK.

Guest JF, Clegg JP, Davie AM, McCloskey E. Guest JF, et al. Curr Med Res Opin. 2005 May;21(5):805-15. doi: 10.1185/030079905X40472. Curr Med Res Opin. 2005. PMID: 15969880

9

Clinical and economic impact of using macrogol 3350 plus electrolytes in an outpatient setting compared to enemas and suppositories and manual evacuation to treat paediatric faecal impaction based on actual clinical practice in England and Wales.

Guest JF, Candy DC, Clegg JP, Edwards D, Helter MT, Dale AK, Fell J, Cosgrove M, Debelle G. Guest JF, et al. Among authors: clegg jp. Curr Med Res Opin. 2007 Sep;23(9):2213-25. doi: 10.1185/030079907X210462. Curr Med Res Opin. 2007. PMID: 17692152

10

Modelling the costs and consequences of treating paediatric faecal impaction in Australia.

Guest JF, Clegg JP. Guest JF, et al. Curr Med Res Opin. 2006 Jan;22(1):107-19. doi: 10.1185/030079905X65583. Curr Med Res Opin. 2006. PMID: 16393437

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

806 results

Search Page